Nexalin Tech Financials
This page shows Nexalin Tech (NXL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Nexalin Tech has an operating margin of -2781.7%, meaning the company retains $-2782 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -4596.1% the prior year.
Nexalin Tech's revenue surged 78.8% year-over-year to $302K, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Nexalin Tech carries a low D/E ratio of 0.24, meaning only $0.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 4.85, Nexalin Tech holds $4.85 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 97/100.
Nexalin Tech generates a -219.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -206.9% the prior year.
Nexalin Tech passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Nexalin Tech generates $0.60 in operating cash flow (-$5.0M OCF vs -$8.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Nexalin Tech earns $-1018.3 in operating income for every $1 of interest expense (-$8.4M vs $8K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Nexalin Tech generated $302K in revenue in fiscal year 2025. This represents an increase of 78.8% from the prior year.
Nexalin Tech reported -$8.2M in net income in fiscal year 2025. This represents a decrease of 8.1% from the prior year.
Nexalin Tech earned $-0.50 per diluted share (EPS) in fiscal year 2025. This represents an increase of 39.8% from the prior year.
Cash & Balance Sheet
Nexalin Tech held $655K in cash against $0 in long-term debt as of fiscal year 2025.
Nexalin Tech had 21M shares outstanding in fiscal year 2025. This represents an increase of 54.7% from the prior year.
Margins & Returns
Nexalin Tech's gross margin was 79.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the prior year.
Nexalin Tech's operating margin was -2781.7% in fiscal year 2025, reflecting core business profitability. This is up 1814.4 percentage points from the prior year.
Nexalin Tech's net profit margin was -2725.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1783.0 percentage points from the prior year.
Nexalin Tech's ROE was -219.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 12.4 percentage points from the prior year.
Capital Allocation
Nexalin Tech invested $1.1M in research and development in fiscal year 2025. This represents a decrease of 9.0% from the prior year.
NXL Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18K-74.3% | $71K+72.1% | $41K+50.9% | $27K-24.6% | $36K+34.2% | $27K-65.9% | $79K+283.1% | $21K |
| Cost of Revenue | $4K-82.7% | $23K+68.4% | $14K+80.9% | $7K-40.9% | $13K+75.2% | $7K-20.8% | $9K+75.0% | $5K |
| Gross Profit | $14K-70.3% | $48K+73.9% | $27K+39.5% | $20K-15.7% | $23K+19.1% | $20K-71.8% | $70K+354.2% | $15K |
| R&D Expenses | $227K+0.3% | $226K-44.4% | $406K-44.9% | $737K+312.9% | $179K+5.4% | $169K+60.3% | $106K+47.8% | $71K |
| SG&A Expenses | $1.4M+58.9% | $894K-3.8% | $929K-31.2% | $1.4M-24.9% | $1.8M+200.1% | $599K+23.9% | $483K+155.4% | -$873K |
| Operating Income | -$2.3M-44.7% | -$1.6M+19.4% | -$2.0M+30.1% | -$2.9M-14.6% | -$2.5M-93.4% | -$1.3M-20.8% | -$1.1M+33.9% | -$1.6M |
| Interest Expense | -$2K+51.2% | -$5K-325.2% | -$1K+39.5% | -$2K-82.3% | -$1K-1415.2% | -$66+78.3% | -$304-101.6% | $19K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$2.3M-44.0% | -$1.6M+20.5% | -$2.0M+29.8% | -$2.8M-15.7% | -$2.4M-90.6% | -$1.3M-23.4% | -$1.0M-33.4% | -$781K |
| EPS (Diluted) | $-0.13-30.0% | $-0.10+33.3% | $-0.15 | N/A | $-0.23-35.3% | $-0.17-21.4% | $-0.14 | N/A |
NXL Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1M-21.9% | $6.6M+126.3% | $2.9M-31.3% | $4.2M-19.7% | $5.3M+236.3% | $1.6M-44.8% | $2.8M-22.0% | $3.6M |
| Current Assets | $4.8M-23.2% | $6.3M+139.2% | $2.6M-33.8% | $4.0M-19.3% | $4.9M+315.1% | $1.2M-53.9% | $2.6M-25.3% | $3.4M |
| Cash & Equivalents | $590K+36.8% | $431K-30.7% | $622K+8.3% | $574K+605.6% | $81K-90.4% | $849K+55.4% | $546K-5.9% | $580K |
| Inventory | $160K-7.4% | $173K-1.3% | $175K+0.4% | $175K+10.2% | $158K+9.1% | $145K-5.5% | $154K-1.8% | $156K |
| Accounts Receivable | $8K-86.8% | $60K+313.3% | $14K+11.0% | $13K-14.0% | $15K+29.4% | $12K+219.7% | $4K-60.9% | $9K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $358K-40.5% | $601K+4.5% | $575K+5.1% | $547K+82.6% | $299K+41.2% | $212K-58.2% | $507K+19.3% | $425K |
| Current Liabilities | $358K-40.5% | $601K+4.5% | $575K+5.1% | $547K+82.6% | $299K+41.2% | $212K-58.2% | $507K+19.3% | $425K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $4.8M-20.0% | $6.0M+156.4% | $2.3M-36.7% | $3.7M-25.9% | $5.0M+267.0% | $1.4M-41.9% | $2.3M-27.4% | $3.2M |
| Retained Earnings | -$90.5M-2.6% | -$88.2M-1.8% | -$86.6M-2.3% | -$84.6M-3.5% | -$81.8M-3.1% | -$79.4M-1.6% | -$78.1M-1.4% | -$77.0M |
NXL Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.5M-59.9% | -$917K+35.7% | -$1.4M-25.7% | -$1.1M-41.8% | -$800K+35.8% | -$1.2M-63.3% | -$763K+24.0% | -$1.0M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $1.6M+141.5% | -$3.9M-366.0% | $1.5M-9.4% | $1.6M+136.3% | -$4.5M-389.4% | $1.5M+112.4% | $729K-40.4% | $1.2M |
| Financing Cash Flow | $0 | N/A | N/A | $0 | N/A | N/A | N/A | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NXL Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.3%+10.6pp | 67.7%+0.7pp | 66.9%-5.5pp | 72.4%+7.6pp | 64.8%-8.2pp | 73.0%-15.4pp | 88.4%+13.8pp | 74.5% |
| Operating Margin | -12924.3%-10628.1pp | -2296.2%+2607.4pp | -4903.6%+5675.8pp | -10579.5%-3617.4pp | -6962.1%-2129.7pp | -4832.4%-3467.6pp | -1364.8%+6545.9pp | -7910.8% |
| Net Margin | -12542.4%-10302.6pp | -2239.7%+2608.1pp | -4847.8%+5576.7pp | -10424.5%-3629.6pp | -6794.9%-2009.1pp | -4785.7%-3462.3pp | -1323.4%+2478.2pp | -3801.7% |
| Return on Equity | -47.7%-21.2pp | -26.5%+59.0pp | -85.5%-8.4pp | -77.1%-27.7pp | -49.4%+45.7pp | -95.1%-50.3pp | -44.7%-20.4pp | -24.3% |
| Return on Assets | -44.4%-20.3pp | -24.1%+44.5pp | -68.6%-1.5pp | -67.1%-20.5pp | -46.6%+35.6pp | -82.2%-45.4pp | -36.7%-15.3pp | -21.5% |
| Current Ratio | 13.47+3.0 | 10.44+5.9 | 4.56-2.7 | 7.25-9.1 | 16.39+10.8 | 5.57+0.5 | 5.05-3.0 | 8.06 |
| Debt-to-Equity | 0.07-0.0 | 0.10-0.1 | 0.25+0.1 | 0.15+0.1 | 0.06-0.1 | 0.16-0.1 | 0.22+0.1 | 0.13 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Nexalin Tech's annual revenue?
Nexalin Tech (NXL) reported $302K in total revenue for fiscal year 2025. This represents a 78.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nexalin Tech's revenue growing?
Nexalin Tech (NXL) revenue grew by 78.8% year-over-year, from $169K to $302K in fiscal year 2025.
Is Nexalin Tech profitable?
No, Nexalin Tech (NXL) reported a net income of -$8.2M in fiscal year 2025, with a net profit margin of -2725.8%.
What is Nexalin Tech's gross margin?
Nexalin Tech (NXL) had a gross margin of 79.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nexalin Tech's operating margin?
Nexalin Tech (NXL) had an operating margin of -2781.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Nexalin Tech's net profit margin?
Nexalin Tech (NXL) had a net profit margin of -2725.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Nexalin Tech's return on equity (ROE)?
Nexalin Tech (NXL) has a return on equity of -219.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Nexalin Tech's operating cash flow?
Nexalin Tech (NXL) generated -$5.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Nexalin Tech's total assets?
Nexalin Tech (NXL) had $4.6M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Nexalin Tech spend on research and development?
Nexalin Tech (NXL) invested $1.1M in research and development during fiscal year 2025.
What is Nexalin Tech's current ratio?
Nexalin Tech (NXL) had a current ratio of 4.85 as of fiscal year 2025, which is generally considered healthy.
What is Nexalin Tech's debt-to-equity ratio?
Nexalin Tech (NXL) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nexalin Tech's return on assets (ROA)?
Nexalin Tech (NXL) had a return on assets of -177.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Nexalin Tech's cash runway?
Based on fiscal year 2025 data, Nexalin Tech (NXL) had $655K in cash against an annual operating cash burn of $5.0M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Nexalin Tech's Piotroski F-Score?
Nexalin Tech (NXL) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nexalin Tech's earnings high quality?
Nexalin Tech (NXL) has an earnings quality ratio of 0.60x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Nexalin Tech cover its interest payments?
Nexalin Tech (NXL) has an interest coverage ratio of -1018.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Nexalin Tech?
Nexalin Tech (NXL) scores 59 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.